Acetadote Injection, Solution
Product Images NDC 66220-207

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Acetadote (NDC 66220-207). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cumberland Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ace16 0016 01

FDA Label Image

Ace16 0016 02

FDA Label Image

Ace16 0016 03

This text appears to be a description of a medication called Acetadote, which is contained in a 30mL single dose vial. The medication is meant to be injected intravenously, and must be further diluted prior to use. The active ingredient is acetylcysteine at a concentration of 200 mg/mL, and the inactive ingredients are sterile water and sodium hydroxide. The medication is stored sterile and should be discarded if unused. The manufacturer is Cumberland Pharmaceuticals Inc. and the medication is only available by prescription.*

FDA Label Image

Ace16 0016 04

This is a product description for Acetadote® Injection, which contains acetylcysteine in a concentration of 200mg/mL, with each vial containing 30mL of the solution. The listing appears twice, indicating that it may be part of a bulk package of 4 vials, but no further information is provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.